AIM ImmunoTech Inc. · AMEX:AIM
Equels Thomas K bought 39,000 AIM ImmunoTech Inc. shares (Form 4)
Traded Nov 10, 2026 · Filed Nov 12, 2026
On Nov 10, 2026, Equels Thomas K (Director, CEO & President) bought 39,000 AIM ImmunoTech Inc. shares at US$0.14 for US$5,382, leaving 293,095 shares. Filed Nov 12, 2026 (Form 4).
- Bought
- 39,000 shares
- Price
- US$0.14
- Value
- US$5,382
- Holding after
- 293,095 shares
- Trading plan
- No
- Role
- Director, CEO & President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Stock | Buy | 39,000 | US$0.14 | 293,095 | Direct |
Source
Download original · View original at SEC
Related
- AIM ImmunoTech Inc.
- Equels Thomas K
- AIM ImmunoTech Inc. shareholders
- Form 4 · Equels Thomas K · Nov 20, 2026
- Form 4 · Equels Thomas K · Nov 18, 2026
- Form 4 · Equels Thomas K · Nov 17, 2026
- Form 4 · Equels Thomas K · Nov 13, 2026
- Form 4 · Equels Thomas K · Nov 10, 2026
- Form 4 · Kellner Ted D · Nov 20, 2026
- Form 4 · Equels Thomas K · Nov 9, 2026
- Form 4 · Equels Thomas K · Nov 6, 2026
- Form 4 · Equels Thomas K · Oct 26, 2026
- Form 4 · Equels Thomas K · Oct 23, 2026